BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23926301)

  • 1. Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma.
    Bonetti P; Testoni M; Scandurra M; Ponzoni M; Piva R; Mensah AA; Rinaldi A; Kwee I; Tibiletti MG; Iqbal J; Greiner TC; Chan WC; Gaidano G; Piris MA; Cavalli F; Zucca E; Inghirami G; Bertoni F
    Blood; 2013 Sep; 122(13):2233-41. PubMed ID: 23926301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.
    Sartori G; Napoli S; Cascione L; Chung EYL; Priebe V; Arribas AJ; Mensah AA; Dall'Angelo M; Falzarano C; Barnabei L; Forcato M; Rinaldi A; Bicciato S; Thome M; Bertoni F
    J Exp Clin Cancer Res; 2021 Nov; 40(1):357. PubMed ID: 34763718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11q24.2q24.3 microdeletion in two families presenting features of Jacobsen syndrome, without intellectual disability: Role of FLI1, ETS1, and SENCR long noncoding RNA.
    Conrad S; Demurger F; Moradkhani K; Pichon O; Le Caignec C; Pascal C; Thomas C; Bayart S; Perlat A; Dubourg C; Jaillard S; Nizon M
    Am J Med Genet A; 2019 Jun; 179(6):993-1000. PubMed ID: 30888095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type.
    Priebe V; Sartori G; Napoli S; Chung EYL; Cascione L; Kwee I; Arribas AJ; Mensah AA; Rinaldi A; Ponzoni M; Zucca E; Rossi D; Efremov D; Lenz G; Thome M; Bertoni F
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice Haploinsufficient for Ets1 and Fli1 Display Middle Ear Abnormalities and Model Aspects of Jacobsen Syndrome.
    Carpinelli MR; Kruse EA; Arhatari BD; Debrincat MA; Ogier JM; Bories JC; Kile BT; Burt RA
    Am J Pathol; 2015 Jul; 185(7):1867-76. PubMed ID: 26093983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor ETS1 in lymphomas: friend or foe?
    Testoni M; Chung EY; Priebe V; Bertoni F
    Leuk Lymphoma; 2015 Jul; 56(7):1975-80. PubMed ID: 25363344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mouse and human Fli1 genes are similarly regulated by Ets factors in T cells.
    Svenson JL; Chike-Harris K; Amria MY; Nowling TK
    Genes Immun; 2010 Mar; 11(2):161-72. PubMed ID: 19829305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.
    Chung EYL; Sartori G; Ponzoni M; Cascione L; Priebe V; Xu-Monette ZY; Fang X; Zhang M; Visco C; Tzankov A; Rinaldi A; Sgrignani J; Zucca E; Rossi D; Cavalli A; Inghirami G; Scott DW; Young KH; Bertoni F
    Br J Haematol; 2023 Oct; 203(2):244-254. PubMed ID: 37584198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma.
    Nagel S; Leich E; Quentmeier H; Meyer C; Kaufmann M; Zaborski M; Rosenwald A; Drexler HG; Macleod RA
    Leuk Lymphoma; 2010 May; 51(5):881-91. PubMed ID: 20367563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma.
    Wenzel SS; Grau M; Mavis C; Hailfinger S; Wolf A; Madle H; Deeb G; Dörken B; Thome M; Lenz P; Dirnhofer S; Hernandez-Ilizaliturri FJ; Tzankov A; Lenz G
    Leukemia; 2013 Jun; 27(6):1381-90. PubMed ID: 23257783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
    Tang SW; Bilke S; Cao L; Murai J; Sousa FG; Yamade M; Rajapakse V; Varma S; Helman LJ; Khan J; Meltzer PS; Pommier Y
    Clin Cancer Res; 2015 Sep; 21(18):4184-93. PubMed ID: 25779942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).
    Carreras J; Kikuti YY; Beà S; Miyaoka M; Hiraiwa S; Ikoma H; Nagao R; Tomita S; Martin-Garcia D; Salaverria I; Sato A; Ichiki A; Roncador G; Garcia JF; Ando K; Campo E; Nakamura N
    Histopathology; 2017 Mar; 70(4):595-621. PubMed ID: 27775850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
    Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF
    Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells.
    Duren RP; Boudreaux SP; Conneely OM
    PLoS One; 2016; 11(3):e0150450. PubMed ID: 26938745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.
    Sebastián E; Alcoceba M; Martín-García D; Blanco Ó; Sanchez-Barba M; Balanzategui A; Marín L; Montes-Moreno S; González-Barca E; Pardal E; Jiménez C; García-Álvarez M; Clot G; Carracedo Á; Gutiérrez NC; Sarasquete ME; Chillón C; Corral R; Prieto-Conde MI; Caballero MD; Salaverria I; García-Sanz R; González M
    Ann Hematol; 2016 Jan; 95(2):253-62. PubMed ID: 26573278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
    Iqbal J; Sanger WG; Horsman DE; Rosenwald A; Pickering DL; Dave B; Dave S; Xiao L; Cao K; Zhu Q; Sherman S; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Ott G; Müller-Hermelink HK; Delabie J; Braziel RM; Jaffe ES; Campo E; Lynch JC; Connors JM; Vose JM; Armitage JO; Grogan TM; Staudt LM; Chan WC
    Am J Pathol; 2004 Jul; 165(1):159-66. PubMed ID: 15215171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
    Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
    Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of the entire FLI1 gene, disrupted by the Ewing's sarcoma translocation breakpoint on 11q24, in a yeast artificial chromosome.
    Selleri L; Giovannini M; Romo A; Zucman J; Delattre O; Thomas G; Evans GA
    Cytogenet Cell Genet; 1994; 67(2):129-36. PubMed ID: 8039423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.